Patient Demographics and Response to JAK Inhibitor Therapy

Published: 17 February 2025| Version 1 | DOI: 10.17632/yp8v2z9kct.1
Contributor:
Aubrey Martin

Description

This table presents a summary of various studies investigating the use of Janus kinase (JAK) inhibitors in treating different forms of scarring alopecia.

Files

Institutions

Lahey Hospital and Medical Center Burlington

Categories

Dermatology, Alopecia

Licence